Glycan characterization of pregnancy-specific glycoprotein 1 and its identification as a novel Galectin-1 ligand
Authors:
- Mirian MendozaMMMirian Mendoza
- Dongli LuDLDongli Lu
- Angela BallesterosABAngela Ballesteros
- Sandra M BloisSBSandra M Blois
- Kelsey AbernathyKAKelsey Abernathy
- Chiguang FengCFChiguang Feng
- Charles J DimitroffCDCharles J Dimitroff
- Jonathan ZmudaJZJonathan Zmuda
- Maria PanicoMPMaria Panico
- Gerardo R VastaGVGerardo R Vasta
- Stuart M HaslamSHStuart M Haslam
Open Access
- 13 April 2020
- journal article
- conference paper
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 30 (11) , 895-909
Abstract
Pregnancy-specific beta 1 glycoprotein (PSG1) is secreted from trophoblast cells of the human placenta in increasing concentrations as pregnancy progresses, becoming one of the most abundant proteins in maternal serum in the third trimester. PSG1 has seven potential N-linked glycosylation sites across its four domains. We carried out glycomic and glycoproteomic studies to characterize the glycan composition of PSG1 purified from serum of pregnant women and identified the presence of complex N-glycans containing poly LacNAc epitopes with α2,3 sialyation at four sites. Using different techniques, we explored whether PSG1 can bind to galectin-1 (Gal-1) as these two proteins were previously shown to participate in processes required for a successful pregnancy. We confirmed that PSG1 binds to Gal-1 in a carbohydrate-dependent manner with an affinity of the interaction of 0.13 μM. In addition, we determined that out of the three N-glycosylation-carrying domains, only the N and A2 domains of recombinant PSG1 interact with Gal-1. Lastly, we observed that the interaction between PSG1 and Gal-1 protects this lectin from oxidative inactivation and that PSG1 competes the ability of Gal-1 to bind to some but not all of its glycoprotein ligands.Keywords
Funding Information
- National Institutes of Health (R21AI120918, R01GM070589)
- Collaborative Health Initiative Research Program (401738)
- National Cancer Institute Alliance of Glycobiologists for Cancer Research: Biological Tumor Glycomics Laboratory (U01 CA225644)
- National Institute of Allergy and Infectious Diseases (R21 AI146368)
- Mizutani Foundation for Glycoscience Research
- Biotechnology and Biological Sciences Research Council (BB/F008309/1)
- Deutsche Forschungsgemeinschaft (BL1115/3–1, BL1115/7–1, BL1115/4–1)
- National Science Foundation (IOS-1656720, IOS-1050518)
- Mizutani Foundation for Glycoscience Research (17–0093)
This publication has 91 references indexed in Scilit:
- Widespread Divergence of the CEACAM/PSG Genes in Vertebrates and Humans Suggests Sensitivity to SelectionPLOS ONE, 2013
- Pregnancy-specific Glycoprotein 1 Induces Endothelial Tubulogenesis through Interaction with Cell Surface ProteoglycansJournal of Biological Chemistry, 2011
- Galectin-1 sensitizes carcinoma cells to anoikis via the fibronectin receptor α5β1-integrinCell Death & Differentiation, 2010
- Glycomics Profiling of Chinese Hamster Ovary Cell Glycosylation Mutants Reveals N-Glycans of a Novel Size and ComplexityJournal of Biological Chemistry, 2010
- The Isolation and Characterization of a Novel Telomerase Immortalized First Trimester Trophoblast Cell Line, Swan 71Placenta, 2009
- A primate subfamily of galectins expressed at the maternal–fetal interface that promote immune cell deathProceedings of the National Academy of Sciences, 2009
- Ligand Reduces Galectin-1 Sensitivity to Oxidative Inactivation by Enhancing Dimer FormationJournal of Biological Chemistry, 2009
- Galectin-1, -2, and -3 Exhibit Differential Recognition of Sialylated Glycans and Blood Group AntigensJournal of Biological Chemistry, 2008
- Severe preeclampsia is characterized by increased placental expression of galectin-1The Journal of Maternal-Fetal & Neonatal Medicine, 2008
- Galectin Binding to Mgat5-Modified N-Glycans Regulates Fibronectin Matrix Remodeling in Tumor CellsMolecular and Cellular Biology, 2006